SurModics
SRDX
$33.33
Share price
29.74%
Change (1 day)
44.98%
Change (1 year)
Categories
SurModics (SRDX) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $58.09 M
According to SurModics's latest financial reports the company's total liabilities are $58.09 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
SurModics - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-09-30 | $65.82 M | 31.73% |
| 2022-09-30 | $49.96 M | -8.33% |
| 2021-09-30 | $54.5 M | 44.55% |
| 2020-09-30 | $37.7 M | 0.96% |
| 2019-09-30 | $37.34 M | -32.73% |
| 2018-09-30 | $55.52 M | 121.78% |
| 2017-09-30 | $25.03 M | -3.93% |
| 2016-09-30 | $26.06 M | 281.18% |
| 2015-09-30 | $6.83 M | 11.39% |
| 2014-09-30 | $6.13 M | -24.28% |
| 2013-09-30 | $8.1 M | -13.13% |
| 2012-09-30 | $9.33 M | -45.67% |
| 2011-09-30 | $17.17 M | 7.88% |
| 2010-09-30 | $15.92 M | 20.7% |
| 2009-09-30 | $13.19 M | -73.2% |
| 2008-09-30 | $49.22 M | 21.81% |
| 2007-09-30 | $40.4 M | 231.25% |
| 2006-09-30 | $12.19 M | 41.13% |
| 2005-09-30 | $8.64 M | -43.42% |
| 2004-09-30 | $15.27 M | 30.64% |
| 2003-09-30 | $11.69 M | 61.23% |
| 2002-09-30 | $7.25 M | 48.54% |
| 2001-09-30 | $4.88 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 169,953.37% | 🇺🇸 USA |
 Abbott Laboratories ABT | $34.38 B | 59,096.08% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | $51.88 B | 89,216.58% | 🇺🇸 USA |
 Agilent Technologies A | $4.76 B | 8,094.18% | 🇺🇸 USA |
 PerkinElmer
PKI | $6.60 B | 11,269.15% | 🇺🇸 USA |
 Alkermes ALKS | $0.93 B | 1,507.05% | 🇮🇪 Ireland |
 Nektar Therapeutics
NKTR | $0.26 B | 359.71% | 🇺🇸 USA |
 Heron Therapeutics HRTX | $0.25 B | 341.52% | 🇺🇸 USA |
 Enzo Biochem ENZ | $28.3 M | -51.28% | 🇺🇸 USA |